Dr Yolanda Markaki
Supervisor Details
Research Interests
Research group activity
Developmental Epigenetics and Nuclear Architecture
Nuclear architecture plays a key role in the regulation of nuclear function and gene expression. Chromatin is organized into intricate specialized neighborhoods within the cell nucleus. These chromatin compartments arise from the local concentration of epigenetic factors and other effector molecules, including non-coding RNAs and architectural proteins, that modulate chromatin structure and gene expression. The three-dimensional organization and composition of our epigenomes is a dynamic process that changes during development or in disease states.
Our research group is interested in deciphering fundamental principles that govern genome architecture and to explore how changes in nuclear compartmentalization and the distribution of epigenetic factors alter gene expression and cellular fate. To understand epigenetic mechanisms, we primarily use X chromosome inactivation (XCI) as a model system. XCI is a fundamental gene regulatory process that takes place in early embryonic development to compensate the imbalance of X-linked gene dosage between XX females and XY males. Once established, the inactive X will be clonally propagated in daughter cells as heritable epigenetic memory. Both active and inactive X chromosome territories carry the same genetic code, yet their structural, molecular and gene expression profiles are profoundly different. Initiation of XCI is essential for the survival and development of female embryos while its maintenance in adult tissues is required to regulate cell identity and physiology. Its dysregulation leads to severe diseases, including immune diseases and cancer by partial or complete X chromosome reactivation.
The long non-coding (lnc) RNA Xist triggers XCI by recruiting to the inactive X an array of epigenetic factors and other effector proteins that induce higher-order chromatin changes and transcriptional repression. Our work has uncovered that Xist forms nanosized supramolecular complexes (SMACs) that regulate the initiation of silencing on the inactive X. SMACs arise from only few RNA molecules, form novel protein-protein interactions that are essential to their function and regulate broad genomic regions. A major unanswered question is how these RNA-seeded supercomplexes change and mature to initiate and maintain transcriptional shutdown during development and then how these are disrupted in pathologies. To address these questions we integrate genetic engineering, cell and molecular biology approaches with cutting-edge quantitative super-resolution microscopy. We use several stem cell and disease models in collaboration with the University Hospitals Leicester and the Leicester Cancer Research Center to understand how changes in genome organization and the composition of epigenetic factors contribute to different expression patterns in development or disease. We collaborate with other groups within the Institute and the Department of Molecular and Cell Biology to obtain a structure-function relationship of epigenetic complexes and protein-protein interactions critical to their function.
Scientific Inspiration
The Nobel laureate Professor Eric Betzig for the development of super-resolution microscopy methods, for illustrating the importance of collaboration and acknowledgement in science and for giving us the most amazing tools to explore the unseen of the living world.
MIBTP Project Details
Current Projects (2025-26)
Primary supervisor for:
Co-supervisor on projects with Dr Thomas Schalch, Dr Andrew Nelson and Dr Hollie Marshall.
Previous Projects (2024-25)
Primary supervisor for:
Co-supervisor on a project with Dr Michael Tellier.
Previous Projects (2023-24)
Primary supervisor for: